Skip to Content

Rule

New Animal Drugs; Change of Sponsor

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Final rule.

SUMMARY:

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor for 16 approved new animal drug applications (NADAs) from Purina Mills, Inc., to Virbac AH, Inc.

DATES:

This rule is effective June 3, 2005.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

David R. Newkirk, Center for Veterinary Medicine (HFV-100), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301-827-6967, e-mail: david.newkirk@fda.gov.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

Purina Mills, Inc., P.O. Box 66812, St. Louis, MO 63166-6812, has informed FDA that it has transferred ownership of, and all rights and interest in, the following 16 approved NADAs to Virbac AH, Inc., 3200 Meacham Blvd., Ft. Worth, TX 76137:

Table 1.

NADA No.21 CFR SectionTrade Name
011-779522.940Purina Pigemia 100
013-214558.274Purina Hygromix-Swine
013-663520.100aPurina Liquid Amprol
040-205520.2380aPurina Horse Wormer Medicated
042-116558.185Purina 6-Day Worm-Kill Feed
042-660558.630Purina Pork-Plus Medicated
043-387558.625Purina Hog Plus II
046-700558.365Statyl
049-729520.2261aPurina Sulfa
097-258558.485Purina Ban Worm For Pigs
099-767558.630Purina Tylan 40 Plus Sulfamethazine
113-748520.1182Purina Oral Pigemia
132-574558.325Purina Check-R-Ton LI
135-941558.485Check-E-Ton BM
136-116520.905dPurina Worm-A-Rest Litter Pack
140-869520.1840Purina Bloat Block; Purina Saf-T-Block BG

Accordingly, the agency is amending the regulations in parts 520, 522, and 558 (21 CFR parts 520, 522, and 558). Sections 520.100a, 520.905d, 520.1182, 520.1840, 520.2261a, 520.2380a, 522.940, 558.185, 558.274, 558.325, 558.365, 558.485, 558.625, and 558.630 will reflect the transfer of ownership and a current format. Sections 520.1182 and 522.940 are being revised to reflect a current format.

In addition, § 520.2380a is being revised to correct the citation for the approved indications for Virbac AH's thiabendazole dewormer approved under NADA 040-205. The citation was corrected in the Federal Register of March 3, 1976 (41 FR 9149), but an error was reintroduced in the 1978 printing of the Code of Federal Regulations. This action is being taken to improve the accuracy of the regulations.

This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.

Start List of Subjects

List of Subjects

and 522

End List of Subjects Start Amendment Part

Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine,

End Amendment Part Start Part Start Printed Page 32489

PART 520—ORAL DOSAGE FORM NEW ANIMAL DRUGS

End Part Start Amendment Part

1. The authority citation for

End Amendment Part Start Authority

Authority: 21 U.S.C. 360b.

End Authority Start Amendment Part

2. Section 520.100a is amended by revising paragraph (b) to read as follows:

End Amendment Part
Amprolium drinking water.
* * * * *

(b) Sponsors. See Nos. 050604 and 051311 in § 510.600(c) of this chapter.

* * * * *
[Amended]
Start Amendment Part

3. Section 520.905d is amended in paragraph (b)(2) by removing “017800” and by adding in its place “051311”.

End Amendment Part Start Amendment Part

4. Section 520.1182 is revised to read as follows:

End Amendment Part
Iron dextran suspension.

(a) Specifications. Each milliliter (mL) of suspension contains 55.56 milligrams (mg) iron as ferric hydroxide in complex with a low molecular weight dextran.

(b) Sponsor. See No. 051311 in § 510.600(c) of this chapter.

(c) Conditions of use in swine—(1) Amount. Administer 100 mg (1.8 mL) orally by automatic dose dispenser.

(2) Indications for use. For the prevention of iron deficiency anemia in baby pigs.

(3) Limitations. Treat each pig within 24 hours of farrowing.

[Amended]
Start Amendment Part

5. Section 520.1840 is amended in paragraph (b)(2) by removing “017800” and by adding in its place “051311”.

End Amendment Part
[Amended]
Start Amendment Part

6. Section 520.2261a is amended in paragraph (a) by removing “017800” and by adding in its place “051311”.

End Amendment Part Start Amendment Part

7. Section 520.2380a is amended by revising the section heading and paragraph (c) to read as follows:

End Amendment Part
Thiabendazole top dressing and mineral protein block.
* * * * *

(c) Sponsors. See sponsors in § 510.600(c) of this chapter for use as in paragraph (e) of this section.

(1) No. 051311 for use as in paragraph (e)(1)(i) of this section.

(2) No. 050604 for use as in paragraph (e)(1)(ii) of this section.

(3) No. 021930 for use as in paragraph (e)(2) of this section.

* * * * *
Start Part

PART 522—IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS

End Part Start Amendment Part

8. The authority citation for

End Amendment Part Start Authority

Authority: 21 U.S.C. 360b.

End Authority Start Amendment Part

9. Section 522.940 is revised to read as follows:

End Amendment Part
Ferric oxide injection.

(a) Specifications. Each milliliter (mL) contains colloidal ferric oxide equivalent to 100 milligrams of iron with a low-viscosity dextrin.

(b) Sponsors. See Nos. 051311 and 053501 in § 510.600(c) of this chapter.

(c) Conditions of use in swine—(1) For prevention of iron deficiency anemia, administer 1 mL by intramuscular injection at 2 to 5 days of age. Dosage may be repeated at 2 weeks of age.

(2) For treatment of iron deficiency anemia, administer 1 to 2 mL by intramuscular injection at 5 to 28 days of age.

Start Part

PART 558—NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS

End Part Start Amendment Part

10. The authority citation for

End Amendment Part Start Authority

Authority: 21 U.S.C. 360b, 371.

End Authority Start Amendment Part

11. Section 558.185 is amended by revising paragraph (b)(2); and by adding paragraph (b)(3) to read as follows:

End Amendment Part
Coumaphos.
* * * * *

(b) * * *

(2) No. 017800 for use of Type A medicated articles containing 11.2 percent coumaphos as in paragraph (e)(1) of this section.

(3) No. 051311 for use of Type A medicated articles containing 1.12 percent coumaphos as in paragraph (e)(1) of this section.

* * * * *
[Amended]
Start Amendment Part

12. Section 558.274 is amended in paragraph (a)(2) by removing “043733” and by adding in its place “Nos. 043733 and 051311”; and in the table in paragraph (c)(1)(ii) in the “Sponsor” column by adding in numerical sequence “051311”.

End Amendment Part
[Amended]
Start Amendment Part

13. Section 558.325 is amended in paragraph (a)(13) by removing “017800” and by adding in its place “051311”; and in paragraphs (d)(2)(ii)(1), (d)(2)(iii)(1), and (d)(2)(iv) in the table in the “Sponsor” column by removing “017800” and by adding in numerical sequence “051311”.

End Amendment Part
[Amended]
Start Amendment Part

14. Section 558.365 is amended in paragraph (a) by removing “017800” and by adding in its place “No. 051311”.

End Amendment Part
[Amended]
Start Amendment Part

15. Section 558.485 is amended in paragraph (b)(5) by removing “017800” and by adding in its place “051311”.

End Amendment Part
[Amended]
Start Amendment Part

16. Section 558.625 is amended in paragraph (b)(5) by removing “017800” and by adding in its place “No. 051311”.

End Amendment Part
[Amended]
Start Amendment Part

17. Section 558.630 is amended in paragraph (b)(5) by removing “017800” and by adding in its place “No. 051311”.

End Amendment Part Start Signature

Dated: May 11, 2005.

Steven D. Vaughn,

Director, Office of New animal Drug Evaluation, Center for Veterinary Medicine.

End Signature End Supplemental Information

[FR Doc. 05-11031 Filed 6-2-05; 8:45 am]

BILLING CODE 4160-01-S